{"schema_version":"1","generated_at":"2026-11-07T03:36:36.698Z","data_as_of":null,"url":"https://www.findmykol.com/kol/david-iberri","json_url":"https://www.findmykol.com/kol/david-iberri/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"david-iberri","name":"David Iberri","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Stanford Medicine","institution_url":"https://www.findmykol.com/institution/stanford-university-school-of-medicine","city":"Stanford","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1821300625","orcid":"0000-0001-8592-9895","openalex":"A5034548332"},"summary":"David Iberri is a Hematology physician affiliated with Stanford Medicine. OpenAlex indexes 43 publications with 873 citations (h-index 10); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":43,"cited_by_count":873,"h_index":10,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02723435","title":"Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"Stanford University","source_url":"https://clinicaltrials.gov/study/NCT02723435","trial_url":"https://www.findmykol.com/trial/NCT02723435"},{"nct":"NCT01904643","title":"Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Stanford University","source_url":"https://clinicaltrials.gov/study/NCT01904643","trial_url":"https://www.findmykol.com/trial/NCT01904643"},{"nct":"NCT01846624","title":"Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"David Iberri","source_url":"https://clinicaltrials.gov/study/NCT01846624","trial_url":"https://www.findmykol.com/trial/NCT01846624"}],"source":"trials"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":50.8,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":50.8,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":18}]},{"area":"Sensory organs","share_pct":28.8,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":28.8,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":20.3,"classes_total":1,"classes":[{"class":"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor","setting":"prescribed","share_pct":20.3,"drugs":[{"name":"Entecavir","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"mixed","data_year":2024,"office_pct":53.5,"facility_pct":46.5},"source":"medicare"},"publications":{"total":43,"shown":5,"withheld":38,"matched_by":"OpenAlex author record","recent":[{"title":"Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy","year":2026,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-026-01474-2","status":"verified"},{"title":"Monoclonal versus monotypic: promoting awareness of terminology and clinical take-aways","year":2026,"journal":"Kidney International","source_url":"https://doi.org/10.1016/j.kint.2025.12.006","status":"verified"},{"title":"B-129 The study of serum monoclonal protein (M-protein) glycosylation patterns for risk stratification in multiple myeloma","year":2026,"journal":"Clinical Chemistry","source_url":"https://doi.org/10.1093/clinchem/hvag086.437","status":"verified"},{"title":"Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma","year":2025,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-025-56486-6","status":"verified"},{"title":"First, do NOHARM: a medical safety benchmark and randomized study of physician and AI teaming on clinical consultations","year":2025,"journal":"arXiv (Cornell University)","source_url":"https://doi.org/10.48550/arxiv.2512.01241","status":"verified"}],"source":"works"},"contact":{"address_1":"300 PASTEUR DR","address_2":"STANFORD MEDICINE RESIDENCY OFFICE, GRANT S101","city":"Stanford","state":"CA","zip":"943052200","phone":"650-498-4560","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1821300625","source":"identity"},"similar":[{"name":"Jeffrey Teuteberg","slug":"jeffrey-teuteberg","institution":"Stanford Medicine","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/jeffrey-teuteberg","json_url":"https://www.findmykol.com/kol/jeffrey-teuteberg/profile.json"},{"name":"Charles Debattista","slug":"charles-debattista","institution":"Stanford Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/charles-debattista","json_url":"https://www.findmykol.com/kol/charles-debattista/profile.json"},{"name":"Jong Yoon","slug":"jong-yoon","institution":"Stanford Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/jong-yoon","json_url":"https://www.findmykol.com/kol/jong-yoon/profile.json"},{"name":"Kimberly Dequattro","slug":"kimberly-dequattro","institution":"Stanford Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/kimberly-dequattro","json_url":"https://www.findmykol.com/kol/kimberly-dequattro/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":38}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-04-26","provider_certified":"2024-04-26","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}